Popular now
Debenhams Group returns to growth amid PLT recovery

Debenhams Group returns to growth amid PLT recovery

Currys appoints Fredrik Tønnesen as Group CEO

Currys appoints Fredrik Tønnesen as Group CEO

Inditex sales rise 5.8% after strong start to summer trading

Inditex sales rise 5.8% after strong start to summer trading

Boots sales surpass pre-pandemic levels in FY22

Boots sales surpass pre-pandemic levels in FY22

On this episode of Talking Shop I’m joined by Alain Bejjani—former Group CEO of Middle East retail giant Majid Al Futtaim, and author of the definitive new book, NEXT: Leading Through the New Realities. Drawing on his childhood in war-torn Beirut, and his experience steering a $9.5bn dollar retail and lifestyle empire through a global pandemic, Alain brings an unmatched perspective on leadership under pressure. Today, we break down his crisis survival playbook for retailers operating in distress. We discuss why resilience must always outpace efficiency, the four assets a brand must protect at all costs, and how to turn macro-turmoil into a long-term direction that scales.

Register to get free articles

No spam Unsubscribe anytime

Want unlimited access? View Plans

Already have an account? Sign in

Boots has seen retail sales exceed pre-pandemic levels as it delivered strong growth for Q4 and the full year ending 31 August 2022.

The group said its performance “significantly” contributed to a 65% increase in full year adjusted operating income for WBA International. 

Its sales results in the period were largely driven by its continuing performance in beauty, health and personal care, as well as its new online healthcare services. 

As a result, Boots.com reportedly maintained its gains made during the pandemic with sales now up over 100% compared to Q4 of 2019. 

The pharmacy brand’s flagship and travel stores also saw a boost in footfall, while multiple heatwaves and a return to travel led to a ‘two bottle summer’ for sunscreen, further driving Q4 sales. 

In healthcare, Boots Online Doctor is in growth as demand for ‘pay as you go’ healthcare services accelerated. Boots is also said to be supporting the NHS in providing vital healthcare services, including its winter flu jab service across almost 2,000 stores. 

In addition, Boots saw retail healthcare sales up nearly 14% in the quarter, driven by continued investment in own label healthcare ranges, including the launch of Boots first own label erectile dysfunction treatment, and the UK’s first treatment for thrush and BV in a single product. 

Sebastian James, managing director of Boots UK, said: “This is a really encouraging set of results. I am especially happy to see more and more customers choosing Boots over others, and our market share rising as a result. In addition, I am pleased with the progress we are making in quickly introducing new beauty brands and our healthcare services supporting the NHS.

“We know that cost of living will be a big consideration for everybody and we have frozen 1,500 prices, launched Boots everyday with excellent products for as little as 50p, and massively expanded our Price Advantage scheme.” 

He added: “Finally, I want to say a huge thank you to the 50,000 plus Boots family who have made this great performance happen.”

Previous Post
Revolution Beauty CEO and exec chair stand down amid audit investigation

Revolution Beauty CEO and exec chair stand down amid audit investigation

Next Post
Marks & Spencer considers moving head office from London

Marks & Spencer considers moving head office from London